Search
Markets
News
Analysis
Tools
Stock Screener
Learn
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
nasdaq-avln
/
Avalyn Pharma Ord Shs (Proposed)
AVLN
Add to Watchlist
30.170
USD
-2.750
-8.35%
Close 07/01, 16:00(ET)
Quotes delayed by 15 min
0.000
USD
0.000
Pre-market 07/02, 09:30 (ET)
1.46B
Market Cap
--
P/E TTM
Avalyn Pharma Ord Shs (Proposed)
30.170
-2.750
-8.35%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
More Details of Company
Avalyn Pharma Ord Shs (Proposed) Info
Ticker Symbol
- -
Company name
- -
IPO date
- -
CEO
- -
Number of employees
- -
Security type
- -
Fiscal year-end
- -
Address
- -
City
- -
Stock exchange
- -
Country
- -
Postal code
- -
Phone
- -
Website
- -
Ticker Symbol
- -
IPO date
- -
CEO
- -
Company Executives of Avalyn Pharma Ord Shs (Proposed)
Name
Name/Position
Position
Shareholding
Change
Dr. Ketan Patel, M.D.
Dr. Ketan Patel, M.D.
Independent Director
Independent Director
--
--
Ms. Lyn Baranowski
Ms. Lyn Baranowski
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Heather D. Turner, J.D.
Ms. Heather D. Turner, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Douglas (Doug) Carlson
Mr. Douglas (Doug) Carlson
Chief Financial Officer, Chief Business Officer
Chief Financial Officer, Chief Business Officer
--
--
Dr. Melissa Rhodes, Ph.D.
Dr. Melissa Rhodes, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Howard M. Lazarus, M.D.
Mr. Howard M. Lazarus, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Tiba Aynechi, Ph.D.
Dr. Tiba Aynechi, Ph.D.
Independent Director
Independent Director
--
--
Ms. Jill Carroll
Ms. Jill Carroll
Independent Director
Independent Director
--
--
Mr. Jon Congleton
Mr. Jon Congleton
Independent Director
Independent Director
--
--
Dr. David Friedman, M.D.
Dr. David Friedman, M.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Ketan Patel, M.D.
Dr. Ketan Patel, M.D.
Independent Director
Independent Director
--
--
Ms. Lyn Baranowski
Ms. Lyn Baranowski
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Heather D. Turner, J.D.
Ms. Heather D. Turner, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Douglas (Doug) Carlson
Mr. Douglas (Doug) Carlson
Chief Financial Officer, Chief Business Officer
Chief Financial Officer, Chief Business Officer
--
--
Dr. Melissa Rhodes, Ph.D.
Dr. Melissa Rhodes, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Howard M. Lazarus, M.D.
Mr. Howard M. Lazarus, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
FAQs
Who are the top five shareholders of Avalyn Pharma Ord Shs (Proposed)?
The top five shareholders of Avalyn Pharma Ord Shs (Proposed) are: Dr. Ketan Patel, M.D.